Skip to main content

Table 1 Baseline characteristics of the coeliac disease study group

From: Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study

  All Female Male
n = 700 n = 534 (76% ) n = 166 (24% )
Median age (range), years 49 (16–84) 48 (16–84) 53 (16–83)
Clinical presentation, %    
  Gastrointestinal symptoms and signs 70 70 70
  Extraintestinal symptoms 9 8 12
  Detected by screening* 21 22 18
Duration of symptoms    
  Median (range), years 3 (0–59) 3 (0–51) 2 (0–59)
  25-75th percentile 1-7 1-7 1-5
OEGD at diagnosis, % 100 100 100
OEGD prior to diagnosis of CD, % * 21 19 27
Diagnosis was established in, %    
  Primary health care 52 55 42
  Secondary health care 38 36 44
  Tertiary health care 10 9 14
  1. OEGD oesphago-gastroduodenoscopy.
  2. CD coeliac disease.
  3. * Screening performed because of patients belonged to a risk group (first-degree relatives of coeliac disease patients, those with type 1 diabetes mellitus, autoimmune thyroid disease, Sjögren’s syndrome and IgA deficiency).
  4. Other than the oesphago-gastroduodenoscopy by which the diagnosis of coeliac disease was confirmed.